Telo Genomics Corp. (TSXV:TELO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0750
0.00 (0.00%)
Sep 2, 2025, 2:34 PM EDT
Market Cap7.53M
Revenue (ttm)n/a
Net Income (ttm)-2.61M
Shares Out100.43M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume29,000
Average Volume44,773
Open0.0800
Previous Close0.0750
Day's Range0.0750 - 0.0800
52-Week Range0.0700 - 0.1950
Beta0.04
RSI47.85
Earnings DateSep 26, 2025

About Telo Genomics

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada. Its TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability to identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SMM (Smolde... [Read more]

Sector Healthcare
CEO Sabine Mai
Employees 6
Stock Exchange TSX Venture Exchange
Ticker Symbol TELO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.